161 related articles for article (PubMed ID: 9056013)
1. Antimalarial activity of the bisquinoline trans-N1,N2-bis (7-chloroquinolin-4-yl)cyclohexane-1,2-diamine: comparison of two stereoisomers and detailed evaluation of the S,S enantiomer, Ro 47-7737.
Ridley RG; Matile H; Jaquet C; Dorn A; Hofheinz W; Leupin W; Masciadri R; Theil FP; Richter WF; Girometta MA; Guenzi A; Urwyler H; Gocke E; Potthast JM; Csato M; Thomas A; Peters W
Antimicrob Agents Chemother; 1997 Mar; 41(3):677-86. PubMed ID: 9056013
[TBL] [Abstract][Full Text] [Related]
2. Bisquinolines. 1. N,N-bis(7-chloroquinolin-4-yl)alkanediamines with potential against chloroquine-resistant malaria.
Vennerstrom JL; Ellis WY; Ager AL; Andersen SL; Gerena L; Milhous WK
J Med Chem; 1992 May; 35(11):2129-34. PubMed ID: 1597862
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Plasmodium falciparum to artemisinins and Plasmodium vivax to chloroquine in Phuoc Chien Commune, Ninh Thuan Province, south-central Vietnam.
Phong NC; Chavchich M; Quang HH; San NN; Birrell GW; Chuang I; Martin NJ; Manh ND; Edstein MD
Malar J; 2019 Jan; 18(1):10. PubMed ID: 30654808
[TBL] [Abstract][Full Text] [Related]
4. Bisquinolines. 2. Antimalarial N,N-bis(7-chloroquinolin-4-yl)heteroalkanediamines.
Vennerstrom JL; Ager AL; Dorn A; Andersen SL; Gerena L; Ridley RG; Milhous WK
J Med Chem; 1998 Oct; 41(22):4360-4. PubMed ID: 9784111
[TBL] [Abstract][Full Text] [Related]
5. Contrasting ex vivo efficacies of "reversed chloroquine" compounds in chloroquine-resistant Plasmodium falciparum and P. vivax isolates.
Wirjanata G; Sebayang BF; Chalfein F; Prayoga ; Handayuni I; Noviyanti R; Kenangalem E; Poespoprodjo JR; Burgess SJ; Peyton DH; Price RN; Marfurt J
Antimicrob Agents Chemother; 2015 Sep; 59(9):5721-6. PubMed ID: 26149984
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
7. Quantitative characterization of hemozoin in Plasmodium berghei and vivax.
Pisciotta JM; Scholl PF; Shuman JL; Shualev V; Sullivan DJ
Int J Parasitol Drugs Drug Resist; 2017 Apr; 7(1):110-119. PubMed ID: 28279945
[TBL] [Abstract][Full Text] [Related]
8. In vitro activity of bisquinoline WR268,668 against African clones and isolates of Plasmodium falciparum.
Basco LK; Andersen SL; Milhous WK; Le Bras J; Vennerstrom JL
Am J Trop Med Hyg; 1994 Feb; 50(2):200-5. PubMed ID: 8116813
[TBL] [Abstract][Full Text] [Related]
9. The chemotherapy of rodent malaria. LII. Response of Plasmodium yoelii ssp. NS to mefloquine and its enantiomers.
Peters W; Robinson BL; Mittelholzer ML; Crevoisier C; Stürchler D
Ann Trop Med Parasitol; 1995 Oct; 89(5):465-8. PubMed ID: 7495359
[TBL] [Abstract][Full Text] [Related]
10. A study of the sensitivity of Plasmodium falciparum to chloroquine and mefloquine using the in vitro microtechnique in Peninsular Malaysia.
Ho KB; Mak JW; Ramadas M
Trans R Soc Trop Med Hyg; 1987; 81(2):257-9. PubMed ID: 3303483
[TBL] [Abstract][Full Text] [Related]
11. Antimalarial drug susceptibility testing of Plasmodium falciparum in Thailand using a microdilution radioisotope method.
Webster HK; Boudreau EF; Pavanand K; Yongvanitchit K; Pang LW
Am J Trop Med Hyg; 1985 Mar; 34(2):228-35. PubMed ID: 3885770
[TBL] [Abstract][Full Text] [Related]
12. Susceptibility of Plasmodium falciparum to chloroquine and mefloquine in Somalia.
Warsame M; Lebbad M; Ali S; Wernsdorfer WH; Björkman A
Trans R Soc Trop Med Hyg; 1988; 82(2):202-4. PubMed ID: 3055452
[TBL] [Abstract][Full Text] [Related]
13. JPC-2997, a new aminomethylphenol with high in vitro and in vivo antimalarial activities against blood stages of Plasmodium.
Birrell GW; Chavchich M; Ager AL; Shieh HM; Heffernan GD; Zhao W; Krasucki PE; Saionz KW; Terpinski J; Schiehser GA; Jacobus LR; Shanks GD; Jacobus DP; Edstein MD
Antimicrob Agents Chemother; 2015 Jan; 59(1):170-7. PubMed ID: 25331702
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and antimalarial activities of cyclen 4-aminoquinoline analogs.
Khan MO; Levi MS; Tekwani BL; Khan SI; Kimura E; Borne RF
Antimicrob Agents Chemother; 2009 Apr; 53(4):1320-4. PubMed ID: 19171802
[TBL] [Abstract][Full Text] [Related]
15. [Evaluation of the Plasmodium falciparum response to chloroquine, quinine and mefloquine].
Di Santi SM; Camargo Neves VL; Boulos M; Dutra AP; Ramos AM; Santos M; Barata LC
Rev Inst Med Trop Sao Paulo; 1988; 30(3):147-52. PubMed ID: 3065907
[No Abstract] [Full Text] [Related]
16. Mefloquine is highly efficacious against chloroquine-resistant Plasmodium vivax malaria and Plasmodium falciparum malaria in Papua, Indonesia.
Maguire JD; Krisin ; Marwoto H; Richie TL; Fryauff DJ; Baird JK
Clin Infect Dis; 2006 Apr; 42(8):1067-72. PubMed ID: 16575721
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic responses to different antimalarial drugs in vivax malaria.
Pukrittayakamee S; Chantra A; Simpson JA; Vanijanonta S; Clemens R; Looareesuwan S; White NJ
Antimicrob Agents Chemother; 2000 Jun; 44(6):1680-5. PubMed ID: 10817728
[TBL] [Abstract][Full Text] [Related]
18. Plasmodium falciparum: role of absolute stereochemistry in the antimalarial activity of synthetic amino alcohol antimalarial agents.
Karle JM; Olmeda R; Gerena L; Milhous WK
Exp Parasitol; 1993 Jun; 76(4):345-51. PubMed ID: 8513873
[TBL] [Abstract][Full Text] [Related]
19. In vitro sensitivity of Plasmodium falciparum isolates from Burma to chloroquine quinine and mefloquine.
Lwin M; Zaw M
Southeast Asian J Trop Med Public Health; 1985 Sep; 16(3):453-8. PubMed ID: 2937157
[TBL] [Abstract][Full Text] [Related]
20. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
